Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
about
Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxideAn antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisDefining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against AspergilluDevelopment of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.A quantitative real-time RT-PCR assay for mature C. albicans biofilms.Characterizing the role of cell-wall β-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37.Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.Conidial viability assay for rapid susceptibility testing of Aspergillus species.Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antThe mechanism of antifungal action of essential oil from dill (Anethum graveolens L.) on Aspergillus flavus.Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxiRapid susceptibility testing of medically important zygomycetes by XTT assay.Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms.In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates.Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates.The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.Substrate dependent in vitro antifungal activity of Bacillus sp strain AR2.Identification of limiting factors for the optimum growth of fusarium oxysporum in liquid medium.Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatusConcentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium.Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.Functional assignment of YvgO, a novel set of purified and chemically characterized proteinaceous antifungal variants produced by Bacillus thuringiensis SF361In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.Pentamidine is active in vitro against Fusarium species.Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm.Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosaIn vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serumFlow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazoleAttenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazoleHigh Intracellular Concentrations of Posaconazole Do Not Impact on Functional Capacities of Human Polymorphonuclear Neutrophils and Monocyte-Derived Macrophages In VitroSingle-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation.
P2860
Q28481546-37430B0B-1C4F-4CEE-AFF7-2E0B351D5F4DQ28534020-02114D41-EC7C-4163-8589-849CC8F98BDDQ33517581-FD38BA80-CA03-43B0-9221-042D157FF5A1Q33559702-6F6C9810-8FBA-4364-B7BD-5A5B3820F2CEQ33891605-D6ED76C2-F656-419B-83A9-B73E26DED893Q33945417-01F77CEA-DE48-4AAE-96F7-EF524E8F1C9FQ33956119-2C3FF730-059B-441A-8F6A-829D35A4D32CQ33963764-637E8BC6-49A1-4E62-9089-0A69662317F4Q33974186-4DFA5F66-7AC7-4A48-B47C-FD15D236B7DBQ34137499-70F307F9-A508-4509-A9B1-E82D85FFBDC1Q34301592-41E21593-23F9-4649-B078-321EAD370DD2Q34406720-1AA78773-A0B9-4F81-9C07-BD80DA13E9F2Q34430832-0CE18EA8-F9D3-4D08-9CFE-28C9A6AC09C0Q34529560-40ECB919-A7C0-40ED-8EF9-0D8000A79C96Q34596443-3CA170E7-61EE-4B01-BB44-9A6CFF86FBCDQ34668042-C0D57729-8127-41A2-B67A-6060818C859CQ34977071-197FF002-462C-4D2B-B4C3-94AF64F47832Q35076940-E7337E07-1AE5-47B0-A393-0F1B0527E62FQ35178597-08E66155-1D54-4F26-A86A-0546FC1DD1DFQ35245129-48FD943A-7486-4DA5-BFFC-DDF344C30C1BQ35598556-1D32199F-DE46-46EF-B45D-1B414DB1D10BQ35647724-2878860F-C3A7-4D99-9B3B-5CD66DFDD4D0Q35739749-35069391-8822-4271-936C-9FA54391A3C8Q35840760-B599CDDF-58F8-49AE-AED6-30C38E665422Q35868375-BA53150D-3524-4DEC-B962-0FBB0ED73E00Q35870651-1C9F34A1-1E75-4FC5-98F8-73C8172D2CE8Q35911359-B7C0DE07-130B-4A67-B3C5-3295EBC3D300Q36047714-05B9B2A8-535E-4745-868A-9D93139F2282Q36075919-EB5CD1D9-5693-45A5-B566-139C5DE45376Q36094939-D4CD7B51-BA34-4B2C-9DC8-1304C9FDB7A8Q36407469-E30B80C0-92D9-4F7B-BE3C-0728807DE09DQ36558484-73169B86-C8B6-400A-8FED-77D7C4BD2B3DQ36644611-0E7E9B62-7A44-46D0-ADF5-7E2C70780DD8Q36667135-52BDEA2E-F760-4E3F-A931-E963E36C83CBQ36757617-B8F9675D-EB0A-48E0-ADF3-4BD8BCC282B5Q36880234-87201504-F12F-411D-94E4-2123B70E3D5FQ36880695-1C306187-B471-4F17-82BF-D786528B98E7Q36933346-1A37804F-866D-4F6D-87BB-E537C8D2729EQ37036445-3AF96427-816B-449B-BCAB-92FF309689C9Q37045301-A44C42F8-2DCC-4890-9807-047C0C61192B
P2860
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@ast
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@en
type
label
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@ast
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@en
prefLabel
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@ast
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@en
P2093
P2860
P1476
Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
@en
P2093
B A Bouman
EUROFUNG Network
J Meletiadis
J P Donnelly
J W Mouton
P E Verweij
P2860
P304
P356
10.1128/JCM.39.9.3402-3408.2001
P407
P577
2001-09-01T00:00:00Z